Advanced search
Publication Cover
Expert Review of Neurotherapeutics Volume 6, 2006 - Issue 8
Submit an article Journal homepage
321
Views
44
CrossRef citations to date
0
Altmetric
Review

Blood pressure disorders during Parkinson’s disease: epidemiology, pathophysiology and management

Atul Pathak Laboratoire de Pharmacologie Médicale et Clinique, Inserm U586, Unité de recherche sur les Obésités, Toulouse F-31432 France; Faculté de Médecine, et Club d’Etude du Système Nerveux Autonome, Toulouse F-31000 France. [email protected]
&
Jean-Michel Senard Laboratoire de Pharmacologie Médicale et Clinique, Faculté de Médecine, 37 allées Jules Guesde, 31000 Toulouse, France. [email protected]
Pages 1173-1180 | Published online: 10 Jan 2014

References

  • Mathias CJ. The classification and nomenclature of autonomic disorders: ending chaos, resolving conflict and hopefully achieving clarity. Clin. Auton. Res.5(6), 307–310 (1995).
  • Korczyn AD. Autonomic nervous system disturbances in Parkinson’s disease. In: Advances in Neurology: Parkinson’s Disease: Anatomy, Pathology and Therapy. Streifler MB, Korczyn AD, Melamed E, Youdim MBH (Eds). Raven Press, NY, USA, 53, 463–468 (1990).
  • Pathak A, Senard JM. Pharmacology of orthostatic hypotension in Parkinson’s disease: from pathophysiology to management. Exp. Rev. Cardiovasc. Ther.2(3), 89–99 (2004).
  • Rutan GH, Hermanson B, Bild DE, Kittner SJ, LaBaw F, Tell GS. Orthostatic hypotension in the older adults. The cardiovascular health study. Hypertension19(6), 508–519 (1992).
  • Raïha I, Luutonen S, Piha J, Seppanen A, Toikka T, Sourander L. Prevalence predisposing factors, and prognosis importance of postural hypotension. Arch. Intern. Med.155(9), 930–935 (1995).
  • Elmstahl S, Rosen I. Postural hypotension and EEG variables predict cognitive decline: results from a 5-year follow-up of healthy elderly women. Dement. Geriatr. Cogn. Disord.8(3), 180–187 (1997).
  • Eigenbrodt ML, Rose KM, Couper DJ, Arnett DK, Smith R, Jones D. Orthostatic hypotension as a risk factor for stroke. The Atherosclerosis Risk in Communities (ARIC) study, 1987–1996. Stroke31(10), 2307–2313 (2000).
  • Rose KM, Tyroler HA, Nardo CJ et al. Orthostatic hypotension and the incidence of coronary heart disease: the Atherosclerosis Risk in Communities Study. Am. J. Hypertens13(6), 571–578 (2000).
  • Pathak A, Lapeyre-Mestre M, Montastruc JL, Senard JM. Heat-related morbidity in patients with orthostatic hypotension and primary autonomic failure. Mov. Disord.20(9), 1213–1219 (2005).
  • Masaki KH, Schatz IJ, Burchfiel CM et al. Orthostatic hypotension predicts mortality in elderly men. The Honolulu heart program. Circulation98(21), 2290–2295 (1998).
  • Luukinen H, Koski K, Laippala P, Kivela SL. Prognosis of diastolic and systolic orthostatic hypotension in older persons. Arch. Intern. Med.159(3), 273–280 (1999).
  • The Consensus Committee of the American Autonomic Society and the American Academy of NeurologyConsensus statement on the definition of orthostatic hypotension, pure autonomic failure and multiple system atrophy. Neurology46(5), 1470 (1996).
  • Wakabayashi K, Takahashi H, Ohama E, Takeda S, Ikuta F. Lewy bodies in the visceral autonomic nervous system in Parkinson’s disease. In: Advances in Neurology. Narabayashi H, Nagatsu T, Yanagisawa N, Mizuno Y (Eds). Raven Press, New York, USA, 609–612 (1993).
  • Wenning GK, Scherfler C, Granata R et al. Time course of symptomatic orthostatic hypotension and urinary incontinence in patients with postmortem confirmed parkinsonian syndromes: a clinicopathological study. J. Neurol. Neurosurg. Psychiatry67(5), 620–623 (1999).
  • van Dijk JG, Haan J, Zwinderman K, Kremer B, van Hilten BJ, Roos RA. Autonomic nervous system dysfunction in Parkinson’s disease: relationship with age, medication, duration and severity. J. Neurol. Neurosurg. Psychiatry56(10), 1090–1095 (1993).
  • Senard JM, Raï S, Lapeyre-Mestre M et al. Prevalence of orthostatic hypotension in Parkinson’s disease. J. Neurol. Neurosurg. Psychiatry63(5), 584–589 (1997).
  • Desboeuf K, Grau M, Riche F et al. Prevalence and costs of parkinsonian syndromes associated with orthostatic hypotension. Therapy (2006) (In press).
  • Goldstein DS. Dysautonomia in Parkinson’s disease: neurocardiogical abnormalities. Lancet Neurol.2(11), 669–676 (2003).
  • Kimber JR, Watson L, Mathias CJ. Distinction of Parkinson’s disease from multiple system atrophy by stimulation of growth-hormone release with clonidine. Lancet349(9069), 1877–1881 (1997).
  • Senard JM, Rascol O, Durrieu G et al. Effects of yohimbine on plasma catecholamine levels in orthostatic hypotension related to Parkinson’s disease or multiple system atrophy. Clin. Neuropharmacol.16(1), 70–76 (1993).
  • Braune S, Reinhardt M, Schnitzer R, Riedel A, Lucking CH. Cardiac uptake of [123I]MIBG separates Parkinson’s disease from multiple system atrophy. Neurology53(5), 1020–1025 (1999).
  • Takatsu H, Nishida H, Matsuo H et al. Cardiac sympathetic denervation from the early stage of Parkinson’s disease: clinical and experimental studies with radiolabeled MIBG. J. Nucl. Med.41(1), 71–77 (2000).
  • Courbon F, Brefel-Courbon C, Thalamas C et al. Cardiac MIBG scintigraphy is a sensitive tool for detecting cardiac sympathetic denervation in Parkinson’s disease. Mov. Disord.18(8), 890–897 (2003).
  • Goldstein DS, Eldadah BA, Holmes C et al. Neurocirculatory abnormalities in Parkinson’s disease with orthostatic hypotension. Independence from levodopa treatment. Hypertension46(6), 1333–1339 (2005).
  • Mathias CJ. Postprandial hypotension. Pathophysiological mechanisms and clinical implications in different disorders. Hypertension18(5), 694–704 (1991).
  • Fisher AA, Davis MW, Srikusalanukul W, Budge MM. Postprandial hypotension predicts all-cause mortality in older, low-level care residents. J. Am. Geriatr. Soc.53(8), 1313–1320 (2005).
  • Chaudhuri KR, Ellis C, Love-Jones S et al. Postprandial hypotension and parkinsonian state in Parkinson’s disease. Mov. Disord.12(6), 877–884 (1997).
  • Senard JM, Chamontin B, Rascol A, Montastruc JL. Ambulatory blood pressure in patients with Parkinson’s disease without and with orthostatic hypotension. Clin. Auton. Res.2(2), 99–104 (1992).
  • Verdecchia P. Prognostic value of ambulatory blood pressure. Hypertension35, 844–851 (2000)
  • Fernandez HH, Lapane KL. Predictors of mortality among nursing home residents with a diagnosis of Parkinson’s disease. Med. Sci. Monit.8(4), CR241–CR246 (2002).
  • Korchounov A, Kessler K, Yakhno NN, Damulin IV, Schipper HI. Determinants of autonomic dysfunction in idiopathic Parkinson’s disease. J. Neurol.252, 1530–1536 (2005).
  • Goldstein DS, Pechnik S, Holmes C, Eldadah B, Sharabi Y. Association between supine hypertension and orthostatic hypotension in autonomic failure. Hypertension42(2), 136–142 (2003).
  • Robertson D, Hollister AS, Biaggioni I, Netterville JL, Mosqueda-Garcia R, Robertson RM. The diagnosis and treatment of baroreflex failure. N. Engl. J. Med.329(20), 1449–1455 (1993).
  • Shannon JR, Jordan J, Diedrich A et al. Sympathetically mediated hypertension in autonomic failure. Circulation101(23), 2710–2715 (2000).
  • Senard JM, Valet P, Durrieu G et al. Adrenergic supersensitivity in parkinsonians with orthostatic hypotension. Eur. J. Clin. Invest.20(6), 613–619 (1990).
  • Estan L, Senard JM, Tran MA, Montastruc JL, Berlan M. Reserpine induces vascular α2-adrenergic supersensitivity and platelet α2-adrenoceptor up-regulation in dog. Br. J. Pharmacol.101(2), 329–336 (1990).
  • Shannon J, Jordan J, Costa F, Robertson RM, Biaggioni I. The hypertension of autonomic failure and its treatment. Hypertension30(5), 1062–1067 (1997).
  • Ibrahim MM, Tarazi RC, Dustan HP, Bravo EL. Idiopathic orthostatic hypotension: circulatory dynamics in chronic autonomic insufficiency. Am. J. Cardiol.34, 288–294 (1974).
  • Kronenberg MW, Forman MB, Onrot J, Robertson D. Enhanced left ventricular contractility in autonomic failure: assessment using pressure-volume relations. J. Am. Coll. Cardiol.15(6), 1334–1342 (1990).
  • Biaggioni I, Garcia F, Inagami T, Haile V. Hyporeninemic normoaldosteronism in severe autonomic failure. J. Clin. Endocrinol. Metab.76(3), 580–586 (1993).
  • Ten Harkel AD, van Lieshout JJ, Wieling W. Treatment of orthostatic hypotension with sleeping in the head-up tilt position and in combination with fludrocortisone. J. Intern. Med.232(2), 139–145 (1992).
  • Hakamäki T, Rajala T, Lehtonen A. Ambulatory 24-hour blood pressure recordings in patients with Parkinson’s disease with or without fludrocortisone. Int. J. Clin. Pharmacol. Ther.36(7), 367–370 (1998).
  • McClellan KJ, Wiseman LR, Wilde MI. Midodrine: a review of its therapeutical use in the management of orthostatic hypotension. Drugs & Aging12(1), 76–86 (1998).
  • Desboeuf K, Senard JM, Pavy-Le-Traon A et al. Clinical practice survey of midodrine prescribing in a University hospital. Therapy55(5), 613–617 (2000).
  • Pathak A, Raoul V, Montastruc JL, Senard JM. Adverse drug reactions related to drugs used in orthostatic hypotension: a prospective and systematic pharmacovigilance study in France. Eur. J. Clin. Pharmacol.61(5–6), 471–474 (2005).
  • de Lau LM, Schipper CM, Hofman A, Koudstaal PJ, Breteler MM. Prognosis of Parkinson disease: risk of dementia and mortality: the Rotterdam Study. Arch. Neurol.62(8), 1265–1269 (2005).
  • Fall PA, Saleh A, Fredrickson M, Olsson JE, Granérus AK. Survival time, mortality, and causes of death in elderly patients with Parkinosn’s disease: a 9-year follow-up. Mov. Disord.18(11), 1312–1316 (2003).
  • Donnan PT, Steinke DT, Stubbings C, Davey PG, MacDonald TM. Selegiline and mortality in subjects with Parkinson’s disease: a longitudinal community study. Neurology55(12), 1785–1789 (2000).
  • Wilcox CS, Aminoff MJ, Slater JD. Sodium homeostasis in patients with autonomic failure. Clin. Sci. Mol. Med.53(4), 321–328 (1977).
  • Davidson C, Smith D, Morgan DB. Diurnal pattern of water and electrolyte excretion and body weight in idiopathic orthostatic hypotension. The effect of three treatments. Am. J. Med.61(5), 709–715 (1976).
  • European Society of Hypertension-European Society of Cardiology Guidelines Committee 2003 European Society of Hypertension-European Society of Cardiology guidelines for the management of arterial hypertension. J. Hypertens.21(6), 1011–1053 (2003).
  • Shibao C, Gamboa A, Diedrich A, Biaggioni I. Management of hypertension in the setting of autonomic failure. A pathophysiological approach. Hypertension45(6), 469–476 (2005).
  • Jordan J, Shannon JR, Pohar B et al. Contrasting effects of vasodilators on blood pressure and sodium balance in the hypertension of autonomic failure. J. Am. Soc. Nephrol.10(1), 35–42 (1999).
  • Gaudiot N, Jaubert AM, Charbonnier E et al. Modulation of white adipose tissue lipolysis by nitric oxide. J. Biol. Chem.273(22), 13475–13481 (1998).
  • Harmancey R, Senard JM, Pathak A et al. The vasoactive peptide adrenomedullin is secreted by adipocytes and inhibits lipolysis through NO-mediated β-adrenergic agonist oxidation. FASEB J.19(8), 1045–1047 (2005).
  • Victor RG, Talman WT. Comparative effects of clonidine and dihydroergotamine on venomotor tone and orthostatic tolerance in patients with severe hypoadrenergic orthostatic hypotension. Am. J. Med.112(5), 361–368 (2002).
  • Senard JM, Arias A, Berlan M, Tran MA, Rascol A, Montastruc JL. Pharmacological evidence of α1- and α2-adrenergic supersensitivty in orthostatic hypotension due to spinal cord injury: a case report. Eur. J. Clin. Pharmacol.41(6), 593–596 (1991).
  • Brahmbhatt R, Baggaley P, Hockings B. Normalization of blood pressure in a patient with severe orthostatic hypotension and supine hypertension using clonidine. Hypertension37(6), E24 (2001).
  • Park KH, Long JP, Cannon JG. Reversal of antihypertensive agent-induced postural hypotension with physostigmine. Arch. Int. Pharmacodyn.311, 155–165 (1991).
  • Singer W, Opfer-Gehrking TL, McPhee BR, Hilz MJ, Bharucha AE, Low PA. Acetylcholinesterase inhibition: a novel approach in the treatment of neurogenic orthostatic hypotension. J. Neurol. Neurosurg. Psychiatry74(9), 1294–1298 (2003).
  • Senard JM. Pyridostigmine in the treatment of orthostatic hypotension. Clin. Auton. Res.15(6), 421–422 (2005).
  • Verhaeverbeke I, Mets T. Drug-induced orthostatic hypotension in the elderly. Avoiding its onset. Drug Safety17(2), 105–118 (1997).

Website

  • Randomized, single-blind, placebo-controlled crossover study investigating the effects on supine systolic blood pressure and on pressure natriuresis http://clinicaltrials.gov.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.